Your browser doesn't support javascript.
loading
Cooperative interaction of ets-1 with USF-1 required for HIV-1 enhancer activity in T cells.
Sieweke, M H; Tekotte, H; Jarosch, U; Graf, T.
Affiliation
  • Sieweke MH; EMBL, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
EMBO J ; 17(6): 1728-39, 1998 Mar 16.
Article in En | MEDLINE | ID: mdl-9501094
ABSTRACT
The distal enhancer region of the human immunodeficiency virus 1 (HIV-1) long terminal repeat (LTR) is known to be essential for HIV replication and to contain immediately adjacent E-box and Ets binding sites. Based on a yeast one-hybrid screen we have identified the E-box binding protein USF-1 as a direct interaction partner of Ets-1 and found that the complex acts on this enhancer element. The binding surfaces of USF-1 and Ets-1 map to their DNA-binding domains and although these domains are highly conserved, the interaction is very selective within the respective protein family. USF-1 and Ets-1 synergize in specific DNA binding as well as in the transactivation of reporter constructs containing the enhancer element, and mutations of the individual binding sites dramatically reduce reporter activity in T cells. In addition, a dominant negative Ets-1 mutant inhibits both USF-1-mediated transactivation and the activity of the HIV-1 LTR in T cells. The inhibition is independent of Ets DNA-binding sites but requires the Ets binding surface on USF-1, highlighting the importance of the direct protein-protein interaction. Together these results indicate that the interaction between Ets-1 and USF-1 is required for full transcriptional activity of the HIV-1 LTR in T cells.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / T-Lymphocytes / HIV Enhancer / Proto-Oncogene Proteins / HIV-1 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: EMBO J Year: 1998 Document type: Article Affiliation country: Alemania

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / T-Lymphocytes / HIV Enhancer / Proto-Oncogene Proteins / HIV-1 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: EMBO J Year: 1998 Document type: Article Affiliation country: Alemania